Tangwei Wu
Overview
Explore the profile of Tangwei Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao D, Wu T, Tan Z, Xu J, Lu Z
Expert Rev Anticancer Ther
. 2024 Apr;
24(5):239-251.
PMID: 38594965
Introduction: Non-coding RNAs (ncRNAs), which are incapable of encoding proteins, are involved in the progression of numerous tumors by altering transcriptional and post-transcriptional processing. Recent studies have revealed prominent features...
2.
Chen H, Li X, Chen W, Wu T, Liu S
Int J Med Sci
. 2024 Jan;
21(3):521-529.
PMID: 38250607
Atherosclerosis, a chronic inflammatory disease, poses a significant risk for cardiovascular disorders. Meanwhile, emerging evidence suggests that long noncoding RNAs (lncRNAs) play pivotal roles in diverse cardiovascular conditions. Nonetheless, the...
3.
Wu T, Liu S, Chen W, Zhao D, Lu Z
Int J Med Sci
. 2024 Jan;
21(2):319-331.
PMID: 38169645
Accumulating studies suggest that Huaier exerts anti-tumor effects through intricate mechanisms. Despite extensive research on its efficacy in lung cancer, further investigation is required to elucidate the molecular mechanism of...
4.
Liu S, Chen W, Hu H, Zhang T, Wu T, Li X, et al.
Breast Cancer Res
. 2023 Aug;
25(1):98.
PMID: 37605201
No abstract available.
5.
Wu T, Li X, Yan G, Tan Z, Zhao D, Liu S, et al.
J Exp Clin Cancer Res
. 2023 Apr;
42(1):84.
PMID: 37041574
No abstract available.
6.
Tan Z, Zou Y, Zhu M, Luo Z, Wu T, Zheng C, et al.
BMC Cancer
. 2023 Jan;
23(1):40.
PMID: 36631771
No abstract available.
7.
Wu T, Li X, Yan G, Tan Z, Zhao D, Liu S, et al.
J Exp Clin Cancer Res
. 2023 Jan;
42(1):14.
PMID: 36627684
Background: Metastasis and drug resistance of breast cancer have become a barrier to treating patients successfully. Long noncoding RNAs (lncRNAs) are known as vital players in cancer development and progression. ...
8.
Liu S, Chen W, Hu H, Zhang T, Wu T, Li X, et al.
Breast Cancer Res
. 2021 Dec;
23(1):115.
PMID: 34922601
Background: Mounting evidence supports that long noncoding RNAs (lncRNAs) have critical roles during cancer initiation and progression. In this study, we report that the plasmacytoma variant translocation 1 (PVT1) lncRNA...
9.
Tan Z, Zou Y, Zhu M, Luo Z, Wu T, Zheng C, et al.
BMC Cancer
. 2021 Apr;
21(1):409.
PMID: 33858374
Background: Carnitine palmitoyl transferase 1A (CPT1A), the key regulator of fatty acid oxidation, contributes to tumor metastasis and therapeutic resistance. We aimed to identify its clinical significance as a biomarker...
10.
Wu Z, Li Y, Zhang Y, Hu H, Wu T, Liu S, et al.
Technol Cancer Res Treat
. 2020 Dec;
19:1533033820980426.
PMID: 33353503
Colorectal cancer (CRC) is one of the most common malignant tumors in the digestive tract in humans. The development of colorectal cancer is composed of multiple stages, starting with benign...